Plasma levels of EPA and DHA after ingestion of a single dose of EPA and DHA ethyl esters

Research output: Contribution to journalArticleResearchpeer review

Authors

External Research Organisations

  • The University of Wuppertal
  • Fatty Acid Research Institute (FARI)
View graph of relations

Details

Original languageEnglish
JournalLIPIDS
Publication statusE-pub ahead of print - 19 Sept 2024

Abstract

Omega-3 polyunsaturated fatty acids (n3 PUFA), specifically eicosapentaenoic acid (EPA, 20:5n3), and docosahexaenoic acid (DHA, 22:6n3), are essential for maintaining health. To better understand their biology, it is important to define their bioavailability. The aim of this cross-over study was to investigate and compare the acute effects on plasma EPA and DHA levels after single doses of EPA oil (99% pure) and DHA (97% pure) ethyl esters. Twelve men aged 20-40 years with a body-mass-index of 20-27 kg/m 2 and low fish consumption were recruited. Several measures (e.g., 4-week run-in period, standardized diet, and blood collection protocols) were taken to reduce the inter-individual variability of plasma fatty acids levels. Using a cross-over design, the subjects received 2.2 g of EPA in the first test period and 2.3 g of DHA in the second. The test periods were separated by 2 weeks. Blood samples were taken before dosing and after 2, 4, 6, 8, 12, 24, 48, and 72 h. The mean ± SE maximum concentrations for EPA were higher than for DHA (115 ± 11 μg/mL vs. 86 ± 12 μg/mL; p = 0.05). The mean ± SE incremented area under the plasma concentration curve over 72 h for EPA (2461 ± 279 μg/mL) was 2.4 times higher (p < 0.001) than that for DHA (1021 ± 170 μg/mL). The mean ± SE half-life was for EPA and DHA was 45 ± 8 and 66 ± 12 h. Our results indicate that EPA administration in single doses leads to higher circulating plasma levels of EPA compared to an effect of an equivalent dose of DHA on DHA plasma levels.

Keywords

    bioavailability, docosahexaenoic acid, eicosapentaenoic acid, kinetics, oral single dose, polyunsaturated fatty acid metabolism

ASJC Scopus subject areas

Cite this

Plasma levels of EPA and DHA after ingestion of a single dose of EPA and DHA ethyl esters. / Schmieta, Henrieke Marie-Luise; Greupner, Theresa; Schneider, Inga et al.
In: LIPIDS, 19.09.2024.

Research output: Contribution to journalArticleResearchpeer review

Schmieta, H. M.-L., Greupner, T., Schneider, I., Wrobel, S., Christa, V., Kutzner, L., Hahn, A., Harris, W. S., Schebb, N. H., & Schuchardt, J. P. (2024). Plasma levels of EPA and DHA after ingestion of a single dose of EPA and DHA ethyl esters. LIPIDS. Advance online publication. https://doi.org/10.1002/lipd.12417
Schmieta HML, Greupner T, Schneider I, Wrobel S, Christa V, Kutzner L et al. Plasma levels of EPA and DHA after ingestion of a single dose of EPA and DHA ethyl esters. LIPIDS. 2024 Sept 19. Epub 2024 Sept 19. doi: 10.1002/lipd.12417
Download
@article{3fbe7d688b324ff390171dffb0b0be0e,
title = "Plasma levels of EPA and DHA after ingestion of a single dose of EPA and DHA ethyl esters",
abstract = "Omega-3 polyunsaturated fatty acids (n3 PUFA), specifically eicosapentaenoic acid (EPA, 20:5n3), and docosahexaenoic acid (DHA, 22:6n3), are essential for maintaining health. To better understand their biology, it is important to define their bioavailability. The aim of this cross-over study was to investigate and compare the acute effects on plasma EPA and DHA levels after single doses of EPA oil (99% pure) and DHA (97% pure) ethyl esters. Twelve men aged 20-40 years with a body-mass-index of 20-27 kg/m 2 and low fish consumption were recruited. Several measures (e.g., 4-week run-in period, standardized diet, and blood collection protocols) were taken to reduce the inter-individual variability of plasma fatty acids levels. Using a cross-over design, the subjects received 2.2 g of EPA in the first test period and 2.3 g of DHA in the second. The test periods were separated by 2 weeks. Blood samples were taken before dosing and after 2, 4, 6, 8, 12, 24, 48, and 72 h. The mean ± SE maximum concentrations for EPA were higher than for DHA (115 ± 11 μg/mL vs. 86 ± 12 μg/mL; p = 0.05). The mean ± SE incremented area under the plasma concentration curve over 72 h for EPA (2461 ± 279 μg/mL) was 2.4 times higher (p < 0.001) than that for DHA (1021 ± 170 μg/mL). The mean ± SE half-life was for EPA and DHA was 45 ± 8 and 66 ± 12 h. Our results indicate that EPA administration in single doses leads to higher circulating plasma levels of EPA compared to an effect of an equivalent dose of DHA on DHA plasma levels. ",
keywords = "bioavailability, docosahexaenoic acid, eicosapentaenoic acid, kinetics, oral single dose, polyunsaturated fatty acid metabolism",
author = "Schmieta, {Henrieke Marie-Luise} and Theresa Greupner and Inga Schneider and Sonja Wrobel and Vanessa Christa and Laura Kutzner and Andreas Hahn and Harris, {William S} and Schebb, {Nils Helge} and Schuchardt, {Jan Philipp}",
note = "{\textcopyright} 2024 The Author(s). Lipids published by Wiley Periodicals LLC on behalf of AOCS.",
year = "2024",
month = sep,
day = "19",
doi = "10.1002/lipd.12417",
language = "English",
journal = "LIPIDS",
issn = "0024-4201",
publisher = "John Wiley & Sons Inc.",

}

Download

TY - JOUR

T1 - Plasma levels of EPA and DHA after ingestion of a single dose of EPA and DHA ethyl esters

AU - Schmieta, Henrieke Marie-Luise

AU - Greupner, Theresa

AU - Schneider, Inga

AU - Wrobel, Sonja

AU - Christa, Vanessa

AU - Kutzner, Laura

AU - Hahn, Andreas

AU - Harris, William S

AU - Schebb, Nils Helge

AU - Schuchardt, Jan Philipp

N1 - © 2024 The Author(s). Lipids published by Wiley Periodicals LLC on behalf of AOCS.

PY - 2024/9/19

Y1 - 2024/9/19

N2 - Omega-3 polyunsaturated fatty acids (n3 PUFA), specifically eicosapentaenoic acid (EPA, 20:5n3), and docosahexaenoic acid (DHA, 22:6n3), are essential for maintaining health. To better understand their biology, it is important to define their bioavailability. The aim of this cross-over study was to investigate and compare the acute effects on plasma EPA and DHA levels after single doses of EPA oil (99% pure) and DHA (97% pure) ethyl esters. Twelve men aged 20-40 years with a body-mass-index of 20-27 kg/m 2 and low fish consumption were recruited. Several measures (e.g., 4-week run-in period, standardized diet, and blood collection protocols) were taken to reduce the inter-individual variability of plasma fatty acids levels. Using a cross-over design, the subjects received 2.2 g of EPA in the first test period and 2.3 g of DHA in the second. The test periods were separated by 2 weeks. Blood samples were taken before dosing and after 2, 4, 6, 8, 12, 24, 48, and 72 h. The mean ± SE maximum concentrations for EPA were higher than for DHA (115 ± 11 μg/mL vs. 86 ± 12 μg/mL; p = 0.05). The mean ± SE incremented area under the plasma concentration curve over 72 h for EPA (2461 ± 279 μg/mL) was 2.4 times higher (p < 0.001) than that for DHA (1021 ± 170 μg/mL). The mean ± SE half-life was for EPA and DHA was 45 ± 8 and 66 ± 12 h. Our results indicate that EPA administration in single doses leads to higher circulating plasma levels of EPA compared to an effect of an equivalent dose of DHA on DHA plasma levels.

AB - Omega-3 polyunsaturated fatty acids (n3 PUFA), specifically eicosapentaenoic acid (EPA, 20:5n3), and docosahexaenoic acid (DHA, 22:6n3), are essential for maintaining health. To better understand their biology, it is important to define their bioavailability. The aim of this cross-over study was to investigate and compare the acute effects on plasma EPA and DHA levels after single doses of EPA oil (99% pure) and DHA (97% pure) ethyl esters. Twelve men aged 20-40 years with a body-mass-index of 20-27 kg/m 2 and low fish consumption were recruited. Several measures (e.g., 4-week run-in period, standardized diet, and blood collection protocols) were taken to reduce the inter-individual variability of plasma fatty acids levels. Using a cross-over design, the subjects received 2.2 g of EPA in the first test period and 2.3 g of DHA in the second. The test periods were separated by 2 weeks. Blood samples were taken before dosing and after 2, 4, 6, 8, 12, 24, 48, and 72 h. The mean ± SE maximum concentrations for EPA were higher than for DHA (115 ± 11 μg/mL vs. 86 ± 12 μg/mL; p = 0.05). The mean ± SE incremented area under the plasma concentration curve over 72 h for EPA (2461 ± 279 μg/mL) was 2.4 times higher (p < 0.001) than that for DHA (1021 ± 170 μg/mL). The mean ± SE half-life was for EPA and DHA was 45 ± 8 and 66 ± 12 h. Our results indicate that EPA administration in single doses leads to higher circulating plasma levels of EPA compared to an effect of an equivalent dose of DHA on DHA plasma levels.

KW - bioavailability

KW - docosahexaenoic acid

KW - eicosapentaenoic acid

KW - kinetics

KW - oral single dose

KW - polyunsaturated fatty acid metabolism

UR - http://www.scopus.com/inward/record.url?scp=85204394282&partnerID=8YFLogxK

U2 - 10.1002/lipd.12417

DO - 10.1002/lipd.12417

M3 - Article

C2 - 39299684

JO - LIPIDS

JF - LIPIDS

SN - 0024-4201

ER -

By the same author(s)